EUS-guided tool to check how well beta-blockers work for cirrhosis
Part of Digestive system clinical trials.
This study tests a new way to measure if a type of blood pressure medicine called non-selective beta-blockers (NSBBs) is helping patients with cirrhosis. It uses a thin, flexible tube with a camera (endoscope) to measure pressures in the liver and a nearby vein. If you have cirrhosis with high pressure in the portal vein but haven't started NSBBs yet, this study may help your doctor decide if the medicine is working for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis that is stable (no major complications like jaundice or fluid buildup).
- Your doctor suspects you have high blood pressure in the vein that carries blood to your liver (called portal hypertension).
- You have not yet started taking a non-selective beta-blocker (NSBB) medicine.
- You are willing to have two different types of pressure measurements: one with a thin tube in a neck vein and one with a camera in your stomach.
- You are between 18 and 80 years old, not pregnant, and can give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to measure blood pressure in the main vein of the liver (portal vein) using an endoscope. It may help doctors better understand and manage liver problems without needing a more invasive procedure.
This study uses a special ultrasound with a contrast agent to see if it can diagnose PSVD (a rare liver vessel disorder) without a biopsy. It compares people with PSVD to those with cirrhosis to find better, noninvasive ways to detect this condition.
This trial tests if metformin can lower the pressure in the liver's blood vessels (portal hypertension) in people with cirrhosis. The goal is to see if it can help reduce complications like swelling or bleeding.
This study tests whether using an endoscopic ultrasound to measure the pressure inside blood vessels in the liver can help doctors choose the best treatment for people with advanced liver disease. You may be eligible if you are planning to start a medicine (non-selective beta-blocker) to prevent a first bleed from varices.
This trial uses a minimally invasive ultrasound technique to directly measure blood pressure in the liver's main vein. It may help doctors decide if patients with severe scarred livers need medication to prevent variceal bleeding.
This early-phase study tests a technique to measure blood pressure changes in people with cirrhosis (scarring of the liver). It may help doctors better understand liver circulation problems and guide safer treatment decisions.
Hear when a new Portal Hypertension Related to Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.